Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,946 | 141 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $1,130 | 25 | $0 (2024) |
| ABBVIE INC. | $1,117 | 28 | $0 (2024) |
| RxSight Inc | $615.49 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $607.22 | 16 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $515.03 | 17 | $0 (2024) |
| Alcon Vision LLC | $308.96 | 9 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $243.85 | 5 | $0 (2024) |
| Oyster Point Pharma, Inc. | $235.58 | 5 | $0 (2024) |
| Harrow Eye, LLC | $233.92 | 10 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $172.52 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,020 | 80 | BIOTISSUE HOLDINGS INC. ($498.49) |
| 2023 | $2,467 | 55 | AbbVie Inc. ($570.40) |
| 2022 | $354.28 | 5 | ABBVIE INC. ($238.40) |
| 2021 | $105.27 | 1 | Allergan, Inc. ($105.27) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Ophthalmology | ||||||
| 12/23/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, LIGHT ADJUSTABLE LENS (LAL) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $11.93 | General |
| 12/18/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $95.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: OPTOMETRY | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, LOTEMAX SM | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| 12/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: EYE CARE | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| 11/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $13.68 | General |
| 11/19/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: OPTOMETRY | ||||||
| 11/14/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: EYE CARE | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $6.62 | General |
| 10/31/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: OPTOMETRY | ||||||
| 10/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/19/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $54.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $195.82 | General |
| 10/10/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: EYE CARE | ||||||
| 10/02/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 521 | 593 | $106,854 | $37,031 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $19,532 | $6,997 | 35.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 67 | 78 | $19,756 | $6,557 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 66 | $16,827 | $5,399 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 87 | $15,684 | $5,357 | 34.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 38 | 38 | $11,347 | $4,265 | 37.6% |
| 92134 | Imaging of retina | Office | 2023 | 114 | 122 | $9,845 | $3,465 | 35.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 65 | 65 | $6,126 | $2,290 | 37.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 26 | 38 | $4,773 | $1,655 | 34.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 22 | 22 | $1,613 | $553.14 | 34.3% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 18 | $1,350 | $493.69 | 36.6% |
About Dr. Christopher Cha, OD
Dr. Christopher Cha, OD is a Optometrist healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2021. The National Provider Identifier (NPI) number assigned to this provider is 1871265959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Cha, OD has received a total of $5,946 in payments from pharmaceutical and medical device companies, with $3,020 received in 2024. These payments were reported across 141 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($5,946).
As a Medicare-enrolled provider, Cha has provided services to 521 Medicare beneficiaries, totaling 593 services with total Medicare billing of $37,031. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Fort Worth, TX
- Active Since 09/28/2021
- Last Updated 03/22/2023
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871265959
Products in Payments
- Cequa (Drug) $607.22
- RXSIGHT CONTACT LENS (Device) $591.42
- DURYSTA (Drug) $563.97
- MIEBO (Drug) $489.87
- VUITY (Drug) $425.83
- VYZULTA (Drug) $244.98
- TYRVAYA (Drug) $235.58
- VEVYE (Drug) $233.92
- LUMIGAN (Drug) $232.90
- Rocklatan (Drug) $227.86
- CIRRUS HD-OCT (Device) $134.25
- OXERVATE (Drug) $124.99
- Syfovre (Drug) $114.30
- XDEMVY (Drug) $112.37
- INFUSE (Device) $107.33
- XIIDRA (Drug) $80.54
- LENSAR LASER SYSTEM (Device) $54.95
- iDose (Device) $43.63
- EYSUVIS (Drug) $41.61
- Wavelight Refractive Suite (Device) $39.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Fort Worth
Dr. Robert Chu, O.d, O.D
Optometrist — Payments: $26,453
Dr. Kenneth King, Od, OD
Optometrist — Payments: $23,159
Jennifer Deakins, O.d, O.D
Optometrist — Payments: $22,919
Colette Manning, Od, OD
Optometrist — Payments: $17,412
Bryan Williams, Od, OD
Optometrist — Payments: $11,533
Dr. David Spivey, D.o, D.O
Optometrist — Payments: $9,878